BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2049 related articles for article (PubMed ID: 19829323)

  • 21. Physician-scientists at risk.
    Montgomery EB
    Science; 1999 Mar; 283(5407):1455-6. PubMed ID: 10206872
    [No Abstract]   [Full Text] [Related]  

  • 22. Researchers accused of wanting to rob the poor to give to NIH.
    Wadman M
    Nature; 1998 Aug; 394(6694):609. PubMed ID: 9716118
    [No Abstract]   [Full Text] [Related]  

  • 23. Divisiveness brings uncertainty. Stem-cell researchers look elsewhere for funding.
    Carlson J; Blesch G
    Mod Healthc; 2011 Aug; 41(31):8-9. PubMed ID: 21853567
    [No Abstract]   [Full Text] [Related]  

  • 24. Why French politics and science don't mix.
    Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
    [No Abstract]   [Full Text] [Related]  

  • 25. Why aren't there more scientists advocating for funding?
    Wells RD; Farnham P
    Science; 2006 Nov; 314(5802):1081. PubMed ID: 17110554
    [No Abstract]   [Full Text] [Related]  

  • 26. America's new leadership.
    Goldston D
    Nature; 2008 Nov; 456(7218):16. PubMed ID: 18987708
    [No Abstract]   [Full Text] [Related]  

  • 27. U.S. science policy. NIH stimulus plan triggers flood of applications--and anxiety.
    Kaiser J
    Science; 2009 Apr; 324(5925):318-9. PubMed ID: 19372395
    [No Abstract]   [Full Text] [Related]  

  • 28. National Institutes of Health. Zerhouni's parting message: make room for young scientists.
    Kaiser J
    Science; 2008 Nov; 322(5903):834-5. PubMed ID: 18988813
    [No Abstract]   [Full Text] [Related]  

  • 29. After the doubling.
    Hoofnagle JH
    Hepatology; 2004 Aug; 40(2):275. PubMed ID: 15368429
    [No Abstract]   [Full Text] [Related]  

  • 30. Teetering on the brink.
    Nat Biotechnol; 2010 Oct; 28(10):987. PubMed ID: 20944563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomedical research. Stimulus funding elicits a tidal wave of 'challenge grants'.
    Kaiser J
    Science; 2009 May; 324(5929):867. PubMed ID: 19443754
    [No Abstract]   [Full Text] [Related]  

  • 32. Research funding. Structural disequilibria in biomedical research.
    Teitelbaum MS
    Science; 2008 Aug; 321(5889):644-5. PubMed ID: 18669847
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of NIH funds placed under a spotlight.
    Marris E
    Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193003
    [No Abstract]   [Full Text] [Related]  

  • 34. Sponsored research agreements: balancing risks and benefits.
    Chamblee DA
    Acad Med; 1994 Jun; 69(6):466-7. PubMed ID: 8003160
    [No Abstract]   [Full Text] [Related]  

  • 35. NIH epilepsy branch trials: budgetary and practical issues.
    Jacobs MP
    Epilepsy Res Suppl; 1993; 10():239-44. PubMed ID: 8251102
    [No Abstract]   [Full Text] [Related]  

  • 36. Science and politics: a fatal mix?
    Joachim C
    Nat Mater; 2004 Jul; 3(7):416. PubMed ID: 15229483
    [No Abstract]   [Full Text] [Related]  

  • 37. SBIR program. Researchers fight against bigger slice to small business.
    Mervis J
    Science; 2009 Jul; 325(5936):18. PubMed ID: 19574355
    [No Abstract]   [Full Text] [Related]  

  • 38. Nurturing the biomedical research enterprise.
    Wyngaarden JB
    P R Health Sci J; 1986 Aug; 5(2):43-50. PubMed ID: 3823360
    [No Abstract]   [Full Text] [Related]  

  • 39. EU stalls on funding of ES cell research.
    Meldolesi A
    Nat Biotechnol; 2003 Jun; 21(6):588-9. PubMed ID: 12776131
    [No Abstract]   [Full Text] [Related]  

  • 40. Science agencies prepare for cuts.
    Wadman M
    Nature; 2013 Feb; 494(7436):158-9. PubMed ID: 23407517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.